Mandeg, Chelly G.

HRN: 23-05-53  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2023
AMPICILLIN 1GM (VIAL)
06/18/2023
06/25/2023
IVTT
165mg
Q12
Newborn Affected By Maternal Factors (Maternal UTI)
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes